Hironic Co., Ltd. announced that it expects to receive KRW 3 billion in funding
December 14, 2021
Share
Hironic Co., Ltd. announced that it will issue round 1 unregistered coupon non-guaranteed private convertible bonds for gross proceeds of KRW 3,000,000,000 on December 15, 2021. The transaction will include participation from new investor, Villance-iplus New Technology Association 1. The bonds will mature on December 17, 2024. The bonds have a surface interest rate of 0% and maturity rate of 5%. The bonds are 100% convertible into 411,635 common shares at a conversion price of KRW 7,288 per share from December 17, 2023 to November 17, 2024. The securities are subject to 1 year hold period. The transaction has been approved by the board of directors. The subscription date and payment date is December 17, 2021.
Hironic Co., Ltd is a Korea-based company mainly engaged in the research and development, manufacture and distribution of medical equipment for skin care. The Company mainly manufactures medical equipment for skin and obesity care or treatment. The Companyâs products include MIXEL, a skin cure equipment for skin lesions and melasma, as well as improving skin texture and tone; MIPL, a skin treatment equipment for pigmentation, wrinkle, vascular, acne and hair removal; MIDEPI, a hair removal equipment; DOUBLO, which is skin treatment equipment for skin tightening and rejuvenation, non-invasive lifting for face and eyebrow lifting; MICOOL, a treatment equipment of natural fat cell destruction, and New Midas, which is used for body contouring and face lifting.
HIRONIC CO., LTD. 
